ArticleCurrent microbiology2025
Biological Peptides, Metabolites and Nanoparticles from Potassium-Solubilizing Bacteria: A Recent Horizon in Antimicrobial and Anti-biofilm Strategies.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study reports the isolation and comprehensive characterization of two potent potassium-solubilizing bacterial (KSB) strains, KSB-1 and KSB-5, from the rhizospheric soil of Iris kashmiriana locally named as Mazarmond which is cultivated near graveyard. Iris kashmiriana has antimicrobial and anti-inflammatory activities, being also used to treat stomach disorders and respiratory ailments. Both strains exhibited efficient potassium solubilization on mica-amended Aleksandrov medium, with KSB-1 showing the highest solubilization index (3.00 ± 0.12) and a significant pH drop in broth cultures. Morphological, biochemical, and molecular identification revealed KSB-1 as Priestia megaterium and KSB-5 as Bacillus paramycoides. Peptide profiling via sodium dodecyl sulfate - polyacrylamide gel electrophoresis (SDS-PAGE) and ultra-performance liquid chromatography (UPLC) uncovered unique antimicrobial tetrapeptides rich in arginine, histidine, and proline. Two-dimensional correlation spectroscopy - Fourier transform nuclear magnetic resonance (2D COSY-FTNMR) spectroscopy further identified diverse polar and semi-polar metabolites such as amines, ether, alcohol, aldehydes, alkanes, and carboxylic acid contributing to bioactivity. KSB-5 exhibited superior plant growth promoting (PGPR) traits, including phosphate, silicate, and zinc solubilization, siderophore and IAA production, and strong antifungal activity against Fusarium oxysporum. Anti-biofilm assays showed a 57.03% inhibition by KSB-5 extracts. Field emission scanning electron microscopy (FESEM) and energy dispersive X-ray spectroscopy (EDS) analyses revealed hyphal deformation and deposition of biogenic putative nanoparticles-titanium, selenium, and aluminum-on fungal cells, absent in controls. High resolution transmission electron microscopy (HR-TEM) further confirmed intracellular damage including cytoplasmic disintegration and membrane detachment. This is the first report linking KSB strains from Iris kashmiriana with putative nanoparticle-mediated antifungal and anti-biofilm activities, emphasizing their dual role as biofertilizers and biocontrol agents. The findings highlight their potential application in sustainable agriculture and integrated disease management.
Indexed as
Identifiers
41144015What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.